{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:00:41Z","timestamp":1793149241708,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.biopha.2018.04.021","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T18:12:38Z","timestamp":1524593558000},"page":"923-938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":244,"special_numbering":"C","title":["DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents"],"prefix":"10.1016","volume":"103","author":[{"given":"Tabassum","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaksha","family":"Sankhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasanti","family":"Suvarna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Sherje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhushan","family":"Dravyakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.04.021_bib0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00253-011-3557-z","article-title":"Exploiting bacterial DNA gyrase as a drug target: current state and perspectives","volume":"92","author":"Collin","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2018.04.021_bib0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S003358350800468X","article-title":"DNA topoisomerases: harnessing and constraining energy to govern chromosome topology","volume":"41","author":"Schoeffler","year":"2008","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.biopha.2018.04.021_bib0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/365227a0","article-title":"DNA topoisomerase I is involved in both repression and activation of transcription","volume":"365","author":"Merino","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.04.021_bib0020","doi-asserted-by":"crossref","first-page":"15498","DOI":"10.1016\/S0021-9258(17)40707-1","article-title":"Mammalian topoisomerase I has base mismatch nicking activity","volume":"269","author":"Yeh","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2018.04.021_bib0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/14756366.2012.658785","article-title":"Topoisomerase as target for antibacterial and anticancer drug discovery","volume":"28","author":"Kathiravan","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"14","key":"10.1016\/j.biopha.2018.04.021_bib0030","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1021\/jm300395d","article-title":"Structure-based discovery of substituted 4, 5\u2032-bithiazoles as novel DNA gyrase inhibitors","volume":"55","author":"Brvar","year":"2012","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2018.04.021_bib0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0968-0004(99)01503-0","article-title":"GHKL, an emergent ATPase\/kinase superfamily","volume":"25","author":"Dutta","year":"2000","journal-title":"Trends Biochem. Sci"},{"issue":"3","key":"10.1016\/j.biopha.2018.04.021_bib0040","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0092-8674(85)80074-X","article-title":"DNA gyrase and its complexes with DNA: direct observation by electron microscopy","volume":"41","author":"Kirchhausen","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.04.021_bib0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu. Rev. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2018.04.021_bib0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0966-842X(96)10085-8","article-title":"DNA gyrase as a drug target","volume":"5","author":"Maxwell","year":"1997","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.biopha.2018.04.021_bib0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1568026033452537","article-title":"Fluoroquinolones: action and resistance","volume":"3","author":"Drlica","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.biopha.2018.04.021_bib0060","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1568026033452500","article-title":"The ATP-binding site of type II topoisomerases as a target for antibacterial drugs","volume":"3","author":"Maxwell","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"issue":"10","key":"10.1016\/j.biopha.2018.04.021_bib0065","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1093\/nar\/gki622","article-title":"A monoclonal antibody that inhibits mycobacterial DNA gyrase by a novel mechanism","volume":"33","author":"Manjunatha","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2018.04.021_bib0070","series-title":"DNA Topology","author":"Bates","year":"2005"},{"key":"10.1016\/j.biopha.2018.04.021_bib0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.biopha.2018.04.021_bib0080","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrm831","article-title":"Cellular roles of DNA topoisomerases: a molecular perspective","volume":"3","author":"Wang","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2018.04.021_bib0085","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.bi.65.070196.003223","article-title":"DNA topoisomerases","volume":"65","author":"Wang","year":"1996","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.biopha.2018.04.021_bib0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.pharmtox.41.1.53","article-title":"Tumor cell death induced by topoisomerasetargeting drugs","volume":"41","author":"Li","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.biopha.2018.04.021_bib0095","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jmb.2006.08.052","article-title":"New peptide inhibitors of type IB topoisomerases: similarities and differences vis-a-vis inhibitors of tyrosine recombinases","volume":"363","author":"Fujimoto","year":"2006","journal-title":"J. Mol. Biol."},{"issue":"6645","key":"10.1016\/j.biopha.2018.04.021_bib0100","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/42294","article-title":"Crystal structure of the breakage-reunion domain of DNA gyrase","volume":"388","author":"Cabral","year":"1997","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopha.2018.04.021_bib0105","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/AAC.46.6.1805-1815.2002","article-title":"Quinolone-binding pocket of DNA gyrase: role of GyrB","volume":"46","author":"Heddle","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.biopha.2018.04.021_bib0110","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.str.2007.01.013","article-title":"Modular structure of the full-length DNA gyrase B subunit revealed by small-angle Xray scattering","volume":"15","author":"Costenaro","year":"2007","journal-title":"Structure"},{"issue":"2","key":"10.1016\/j.biopha.2018.04.021_bib0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0092-8674(90)90172-B","article-title":"New topoisomerase essential for chromosome segregation in E. coli","volume":"63","author":"Kato","year":"1990","journal-title":"Cell"},{"issue":"32","key":"10.1016\/j.biopha.2018.04.021_bib0120","doi-asserted-by":"crossref","first-page":"24481","DOI":"10.1016\/S0021-9258(20)80551-1","article-title":"Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions","volume":"268","author":"Peng","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2018.04.021_bib0125","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1074\/jbc.275.6.4112","article-title":"Mutational analysis of Escherichia coli topoisomerase IV. III. Identification of a region of parE involved in covalent catalysis","volume":"275","author":"Bahng","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.04.021_bib0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.biophys.33.110502.140357","article-title":"Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases","volume":"33","author":"Corbett","year":"2004","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"issue":"9","key":"10.1016\/j.biopha.2018.04.021_bib0135","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1021\/bi00304a002","article-title":"Escherichia coli DNA topoisomerase III: purification and characterization of a new type I enzyme","volume":"23","author":"Srivenugopal","year":"1984","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.biopha.2018.04.021_bib0140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"issue":"6","key":"10.1016\/j.biopha.2018.04.021_bib0145","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.biotechadv.2009.05.017","article-title":"Genetic engineering of antibiotic biosynthesis for the generation of new aminocoumarins","volume":"27","author":"Heide","year":"2009","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.biopha.2018.04.021_bib0150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ja.2010.149","article-title":"The genus actinoallomurus and some of its metabolites","volume":"64","author":"Pozzi","year":"2011","journal-title":"J. Antibiot."},{"issue":"3","key":"10.1016\/j.biopha.2018.04.021_bib0155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1023\/A:1010282818272","article-title":"Microbial growth and production kinetics of streptomyces antibioticus T\u00fc 6040","volume":"78","author":"Theobald","year":"2000","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.biopha.2018.04.021_bib0160","series-title":"American Society of Microbiology Antimicrobial Agents","first-page":"13","article-title":"Antibiotics and antibacterial agents: classifications and structure-activity relationship","author":"Bryskier","year":"2005"},{"key":"10.1016\/j.biopha.2018.04.021_bib0165","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1073\/pnas.73.12.4474","article-title":"Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase","volume":"73","author":"Gellert","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2018.04.021_bib0170","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1016\/j.tetlet.2007.05.088","article-title":"Hydrolysis-free synthesis of 3- aminocoumarins","volume":"48","author":"Kudale","year":"2007","journal-title":"Tetrahedron Lett."},{"issue":"1","key":"10.1016\/j.biopha.2018.04.021_bib0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijmm.2013.08.013","article-title":"New aminocoumarin antibiotics as gyrase inhibitors","volume":"304","author":"Heide","year":"2014","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.biopha.2018.04.021_bib0180","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.chembiol.2010.12.016","article-title":"An artificial pathway to 3,4-dihydroxybenzoic acid allows generation of new aminocoumarin antibiotic recognized by catechol transporters of E. coli","volume":"18","author":"Alt","year":"2011","journal-title":"Chem. Biol."},{"issue":"21","key":"10.1016\/j.biopha.2018.04.021_bib0185","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.1016\/j.bmcl.2013.08.094","article-title":"Flavone-based analogues inspired by the natural product simocyclinone D8 as DNA gyrase inhibitors","volume":"23","author":"Verghese","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.biopha.2018.04.021_bib0190","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00203-002-0429-z","article-title":"Cloning and analysis of the simocyclinone biosynthetic gene cluster of streptomyces antibioticus T\u00fc 6040","volume":"178","author":"Galm","year":"2002","journal-title":"Arch. Microbiol."},{"issue":"8","key":"10.1016\/j.biopha.2018.04.021_bib0195","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7164\/antibiotics.53.779","article-title":"Simocyclinones, novel cytostatic angucyclinone antibiotics produced by streptomyces antibioticus Tu 6040 I. Taxonomy, fermentation, isolation and biological activities","volume":"53","author":"Schimana","year":"2000","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"17","key":"10.1016\/j.biopha.2018.04.021_bib0200","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1021\/bi101691k","article-title":"Mass spectrometry reveals that the antibiotic simocyclinone D8 binds to DNA gyrase in a \u201cbent-over\u201d conformation: evidence of positive cooperativity in binding","volume":"50","author":"Edwards","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2018.04.021_bib0205","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.1179123","article-title":"A crystal structure of the bifunctional antibiotic, simocyclinone D8, bound to DNA gyrase","volume":"326","author":"Edwards","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2018.04.021_bib0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1021\/id500013t","article-title":"A new-class antibacterial almost. Lessons in drug discovery and development: a critical analysis of more than 50 years of effort toward ATPase inhibitors of DNA gyrase and topoisomerase IV","volume":"1","author":"Bisacchi","year":"2014","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.biopha.2018.04.021_bib0215","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/j.1460-2075.1996.tb00483.x","article-title":"The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography","volume":"15","author":"Lewis","year":"1996","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.biopha.2018.04.021_bib0220","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/hlca.19960790816","article-title":"Total synthesis of cyclothialidine","volume":"79","author":"Gotschi","year":"1996","journal-title":"Helvetica Chim. Acta"},{"issue":"6","key":"10.1016\/j.biopha.2018.04.021_bib0225","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1021\/jm0310232","article-title":"New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine","volume":"47","author":"Angehrn","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.04.021_bib0230","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1021\/jm060817o","article-title":"Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site","volume":"50","author":"Gradisar","year":"2007","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2018.04.021_bib0235","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1021\/jm401685f","article-title":"Haloemodin as novel antibacterial agent inhibiting DNA gyrase and bacterial topoisomerase I","volume":"57","author":"Duan","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.04.021_bib0240","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.compbiolchem.2015.09.006","article-title":"Identification of chebulinic acid as potent natural inhibitor of M. Tuberculosis DNA gyrase and molecular insights into its binding mode of action","volume":"59","author":"Patel","year":"2015","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.04.021_bib0245","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/jm01240a021","article-title":"1, 8-Naphthyridine derivatives. A new class of chemotherapeutic agents","volume":"91","author":"Lesher","year":"1962","journal-title":"J. Med. Pharm. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2018.04.021_bib0250","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrmicro2333","article-title":"How antibiotics kill bacteria: from targets to networks","volume":"8","author":"Kohanski","year":"2010","journal-title":"Nat. Rev.Microbiol."},{"key":"10.1016\/j.biopha.2018.04.021_bib0255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/dkg208","article-title":"The quinolones: decades of development and use","volume":"51","author":"Emmerson","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"issue":"9","key":"10.1016\/j.biopha.2018.04.021_bib0260","first-page":"2741","article-title":"New classification and update on the quinolone antibiotics","volume":"61","author":"King","year":"2000","journal-title":"Am. Fam. Phys."},{"key":"10.1016\/j.biopha.2018.04.021_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg212","article-title":"Development of the quinolones","volume":"51","author":"Andersson","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.biopha.2018.04.021_bib0270","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2165\/00003495-200059050-00009","article-title":"Gemifloxacin","volume":"59","author":"Lowe","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2018.04.021_bib0275","series-title":"Quinolones:Synthesis and Antibacterial Activity","first-page":"255","author":"Pintilie","year":"2016"},{"issue":"3","key":"10.1016\/j.biopha.2018.04.021_bib0280","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/prot.340010305","article-title":"The DNA replication inhibitor microcin B17 is a forty\u2010three\u2010amino\u2010acid protein containing sixty percent glycine","volume":"1","author":"Davagnino","year":"1986","journal-title":"Proteins Struct Funct. Bioinform."},{"issue":"10","key":"10.1016\/j.biopha.2018.04.021_bib0285","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1073\/pnas.91.10.4519","article-title":"Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor","volume":"91","author":"Yorgey","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2018.04.021_bib0290","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1099\/00221287-132-2-393","article-title":"Microcin B17 blocks DNA replication and induces the SOS system in Escherichia coli","volume":"132","author":"Herrero","year":"1986","journal-title":"Microbiology"},{"issue":"37","key":"10.1016\/j.biopha.2018.04.021_bib0295","doi-asserted-by":"crossref","first-page":"35016","DOI":"10.1074\/jbc.M304516200","article-title":"The action of the bacterial toxin microcin b17 insight into the cleavage-religation reaction of dna gyrase","volume":"278","author":"Pierrat","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2018.04.021_bib0300","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-2836(92)91024-J","article-title":"Control of segregation of chromosomal DNA by sex factor F in Escherichia coli: mutants of DNA gyrase subunit A suppress letD (ccdB) product growth inhibition","volume":"225","author":"Miki","year":"1992","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2018.04.021_bib0305","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0022-2836(92)90629-X","article-title":"Cell killing by the F plasmid CcdB protein involves poisoning of DNA- topoisomerase II complexes","volume":"226","author":"Bernard","year":"1992","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2018.04.021_bib0310","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1006\/jmbi.1997.1357","article-title":"The interaction of the F plasmid killer protein, CcdB, with DNA gyrase: induction of DNA cleavage and blocking of transcription","volume":"273","author":"Critchlow","year":"1997","journal-title":"J. Mol. Biol."},{"issue":"51","key":"10.1016\/j.biopha.2018.04.021_bib0315","doi-asserted-by":"crossref","first-page":"40397","DOI":"10.1074\/jbc.M110.138776","article-title":"Vibrio cholerae ParE2 poisons DNA gyrase via a mechanism distinct from other gyrase inhibitors","volume":"285","author":"Yuan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.04.021_bib0320","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejmech.2014.08.025","article-title":"Pyridine-3- carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: structure based design, synthesis, SAR and antimicrobial activity","volume":"86","author":"Yule","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2018.04.021_bib0325","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijmyco.2015.02.002","article-title":"Benzothiazinone-piperazine derivatives as efficient mycobacterium tuberculosis DNA gyrase inhibitors","volume":"4","author":"Chandran","year":"2015","journal-title":"Int. J. Mycobacteriol."},{"key":"10.1016\/j.biopha.2018.04.021_bib0330","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1128\/AAC.47.3.1037-1046.2003","article-title":"Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling andamino acid substitutions leading to novobiocin resistance","volume":"47","author":"Gross","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.04.021_bib0335","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/AAC.48.5.1856-1864.2004","article-title":"Crystal structures of Escherichia coli topoisomerase IV ParEs subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase","volume":"48","author":"Bellon","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"15","key":"10.1016\/j.biopha.2018.04.021_bib0340","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1021\/acs.jmedchem.5b00863","article-title":"Discovery of novel DNA gyrase inhibiting spiropyrimidinetriones: benzisoxazole fusion with N-linked oxazolidinone substituents leading to a clinical candidate (ETX0914)","volume":"58","author":"Basarab","year":"2015","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.biopha.2018.04.021_bib0345","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.1016\/j.bmcl.2007.09.010","article-title":"N-Benzyl-3 sulfonamidopyrrolidines as inhibitors of cell division in E. coli","volume":"17","author":"Mukherjee","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.biopha.2018.04.021_bib0350","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.bmcl.2017.01.073","article-title":"New 1, 4-dihydro [1, 8] naphthyridine derivatives as DNA gyrase inhibitors","volume":"27","author":"Gen\u00e7er","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2018.04.021_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/bi052130w","article-title":"Pentapeptide repeat proteins","volume":"45","author":"Vetting","year":"2006","journal-title":"Biochemistry"},{"issue":"9105","key":"10.1016\/j.biopha.2018.04.021_bib0360","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(97)07322-4","article-title":"Quinolone resistance from a transferable plasmid","volume":"351","author":"Mart\u00ednez-Mart\u00ednez","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2018.04.021_bib0365","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1128\/AAC.49.1.118-125.2005","article-title":"Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase","volume":"49","author":"Tran","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.biopha.2018.04.021_bib0370","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1128\/AAC.01158-10","article-title":"Structural and biochemical analysis of the pentapeptide repeat protein EfsQnr, a potent DNA gyrase inhibitor","volume":"55","author":"Hegde","year":"2011","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217365794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217365794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T01:28:26Z","timestamp":1720661306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217365794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":74,"alternative-id":["S0753332217365794"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.04.021","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}